CompaniesAsterias Biotherapeutics

Asterias Biotherapeutics

defunct

About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (1)

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

21

By Phase

PHASE2: 1

By Status

COMPLETED: 1

Clinical Trials Pipeline1 trial

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

Today

Hover over trial bars to see details

Recent Trials

NCT00510133Lead Sponsor

A Study of Active Immunotherapy With GRNVAC1 in Patients With Acute Myelogenous Leukemia (AML)

PHASE2Completed

21 participants

Started: Jul 31, 2007 · Completed: Aug 31, 2014

Funding History (20)

8-K

Mar 8, 2019

8-K

Mar 1, 2019

DEFM14A

Feb 4, 2019

8-K

Nov 8, 2018

8-K

Oct 1, 2018

8-K

Sep 18, 2018

8-K

Jun 25, 2018

DEF 14A

Apr 30, 2018

8-K

Dec 5, 2017

8-K

Oct 16, 2017